Fusion Pharmaceuticals In...

NASDAQ: FUSN · Real-Time Price · USD
21.55
0.03 (0.14%)
At close: Jun 03, 2024, 10:00 PM

Fusion Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
61.92M 43.86M 52.9M
Short-Term Investments
172.15M 127.01M 147.9M
Long-Term Investments
14.58M 15.76M 19.99M
Other Long-Term Assets
849K 9.18M 9.42M
Receivables
4.21M 1.72M 357K
Inventory
n/a -9.87M 10.38M
Other Current Assets
5.1M 509K 233K
Total Current Assets
243.4M 179M 211.76M
Property-Plant & Equipment
23.9M 10.31M 9.45M
Goodwill & Intangibles
-849K n/a n/a
Total Long-Term Assets
42.44M 40.07M 40.51M
Total Assets
285.84M 219.06M 252.27M
Account Payables
1.86M 2.69M 2.19M
Deferred Revenue
333K 924K 1.54M
Short-Term Debt
4.16M 1.44M 1.22M
Other Current Liabilities
9.86M 10.01M 7.56M
Total Current Liabilities
16.22M 15.07M 12.51M
Long-Term Debt
34.77M 38.81M 5.51M
Other Long-Term Liabilities
301K 299K 297K
Total Long-Term Liabilities
47.14M 41.78M 8.3M
Total Liabilities
63.36M 56.84M 20.82M
Total Debt
50.33M 40.25M 6.72M
Common Stock
n/a n/a n/a
Retained Earnings
-376.76M -281.86M -194.25M
Comprehensive Income
237K -469K -115K
Shareholders Equity
222.48M 162.22M 231.46M
Total Investments
186.74M 142.77M 167.88M